drugset / Trial / NCT04789486

Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

NCT04789486

Phase 1/2 Recruiting 100 enrolled Dana-Farber Cancer Institute TherAguix S.A. · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

This research study is being done to help determine the safety and efficacy of gadolinium based nanoparticle, Activation and Guidance of Irradiation X (AGuIX), used in conjunction with MR-guided stereotactic body radiation therapy (SBRT) in the treatment of pancreatic cancer and lung tumors.

Timeline

Start
2021-05-27
Primary completion
2028-04-10
Completion
2030-04-10

Drugs

EvaluationDrugModalityDoseRoute
Subject AGuIX Other / unclassified Other